Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon Mar 30, 2021 1:24pm
76 Views
Post# 32906751

MONEY COUNT DOWN

MONEY COUNT DOWNAt the end of the year Liminal had $45 millions in cash and cash equivalent.
During the year 2020 they lost $122 millions.
According to 2020 revenu and expenses, the numbers for 2021 will be like that:

revenu $0
R&D.    $ 60 M
ADM.   $ 9M
Selling and Market $ 40M
Financial cost $3 M

Total.   $112 M.  BURN RATE.  $9,3/ month

On June 1st we will have spent 5X9,3 = $46,5 millions

VERY HARD TIME TO COME... Do your math dreamers !
<< Previous
Bullboard Posts
Next >>